https://www.clinicaltrialsarena.com/news/newsoncomed-begins-phase-ib-immuno-oncology-combination-trial-of-demcizumab-and-pembrolizumab-4842816/
US-based OncoMed Pharmaceuticals has started its Phase Ib trial of investigational agent demcizumab (anti-DLL4, OMP-21M18) in combination with Merck's...
phase iboncomedbeginsimmunooncology
https://www.pharmaceutical-technology.com/uncategorized/newsoncomed-granted-us-patent-for-cancer-stem-cell-vaccine/
OncoMed Pharmaceuticals, a clinical stage company developing medications that target cancer stem cells (CSCs), has confirmed that the United States Patent and...
cancer stem cellus patentoncomedgrantedvaccine